Arsenault Kaitlyn Melanie 的 Form 4/A 修正申報
修正Skye Bioscience, Inc.（SKYE），2025/2/28 申報
- 申報編號
- 0001516551-25-000022
- 申報時間
- 2025/2/28
- 交易日
- 2024/11/15-11/18
- 申報延遲
- 105 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2024/11/19
這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $21.6 萬。交易後 105 天申報。
這份修正申報取代了 0001516551-24-000117（2024/11/19 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Arsenault Kaitlyn MelanieCIK 0001877242 | 高階主管（財務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/11/15 | Common Stock | S賣出處分 | −190 | $5.55 | −$1,054.5 | 210,548 | 直接 | |
| 2024/11/18 | Common Stock | S賣出處分 | −43,026 | $4.99F2 | −$214,699.74 | 167,522 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person.
- F2
The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.
表 I 有 1 筆交易的價格引用這則附註。
備註
This amendment is being filed to correct an inadvertent typographical error in the Original Form 4 in which the number of shares held by the Reporting Person following the transaction was reported as 166,342 instead of 167,522.